Document is current
Any future updates will be listed below
-
Authors
Borges, Maria Carolina
Haycock, Philip C.
Zheng, Jie
Hemani, Gibran
Holmes, Michael V.
Davey Smith, George
Hingorani, Aroon D.
Lawlor, Deborah A.
-
Funding
Funding for this research was provided by:
British Heart Foundation (AA/18/7/34219)
Medical Research Council (MC_UU_00011/1, MC_UU_00011/4, MC_UU_00011/6 and MC_UU_00011/7, MR/P014054/1)
Cancer Research UK (C52724/A20138 & C18281/A29019)
Vice-Chancellor Fellowship
Academy of Medical Sciences (AMS) Springboard Award, the Wellcome Trust, the Government Department of Business, Energy and Industrial Strategy (BEIS), the British Heart Foundation and Diabetes UK (SBF006\1117)
Wellcome Trust (208806/Z/17/Z)
British Heart Foundation (FS/18/23/33512)
National Institute for Health Research Oxford Biomedical Research Centre
National Institute for Health Research (NIHR) Biomedical Research Centre based at University Hospitals Bristol NHS Foundation and the University of Bristol
National Institute of Health Research
British Heart Foundation (CH/F/20/90003)
National Institute of Health Research Senior Investigator (NF-0616-10102)
- License Information
-
More Information
Article History
Received: 29 September 2021
Accepted: 9 May 2022
First Online: 13 June 2022
Declarations
:
: The UK Biobank received ethical approval from the Research Ethics Committee (REC reference for the UK Biobank is 11/NW/0382).
: Not applicable.
: DAL is an Editorial Advisor for BMC Medicine and acknowledges support from Roche Diagnostics and Medtronic Ltd for research unrelated to that presented here. All other authors declare they have no conflict of interest, financial or otherwise.
